1) seawater respiratory distress syndrome(SW-RDS)
海水型呼吸窘迫综合症(SW-RDS)
2) Respiratory distress syndrome
呼吸窘迫综合症
1.
Objective To evaluate the efficacy and safety of pulmonary surfactant(PS)in the replacement therapy for neonatal respiratory distress syndrome(NRDS).
目的 评价肺表面活性物质 (PS)替代治疗新生儿呼吸窘迫综合症 (NRDS )的疗效及安全性。
4) acute respiratory distress syndrome
急性呼吸窘迫综合症
1.
Application and nursing care of end-expiratory positive pressure in treatment of patients with acute respiratory distress syndrome;
呼气末正压在治疗急性呼吸窘迫综合症中的应用及护理
2.
Objective To observe the changes of the levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in acutely isolated alveolar type II (ATII) cells from rats with acute respiratory distress syndrome (ARDS),and test the effects of terbutaline on the cAMP and cGMP levels.
目的观察油酸致大鼠急性呼吸窘迫综合症(ARDS)模型中肺泡II型细胞cAMP、cGMP水平的变化及特布他林的作用。
3.
Objective: To investigate the pathological change of pulmonary after ventilation combined with hypothermia via lung on canines with acute respiratory distress syndromeMethods: Eighteen healthy mutts after anesthesia were induced with oleic acid to be acute respiratory distress syndrome models.
目的研究肺局部低温结合保护性通气在油酸型急性呼吸窘迫综合症(ARDS)动物模型中肺的病理改变。
5) ARDS
急性呼吸窘迫综合症
1.
Object: To observe the effectiveness of partial liquid ventilation(PLA)on gas exchange,pulmonary(cst) and airway resistance in dogs with ARDSMethods: Twelve dogs were randomly allocated to two groups and treated with varions methods after OA ARDS model established.
目的 观察部分液体通气(Paritial Liquid ventilation,PLV)对急性呼吸窘迫综合症犬的肺内气体交换,肺顺应性及肺动静态阻力的影响。
2.
Objective:To summarize the experience in the treatment of thoracic injury accompanied by acute respiratory distress syndrome (ARDS).
目的:总结胸部创伤并发急性呼吸窘迫综合症(ARDS)患者的诊治经验。
6) adult respiratory distress syndrome
成人呼吸窘迫综合症
补充资料：成人型呼吸窘迫综合征
成人型呼吸窘迫综合征
adult respiratory distress syndrome,ARDS
由于重症感染、严重外伤、输大量库存血及多种肺内外原因引起肺顺应性减低，肺泡萎陷不张，肺水肿，肺通气血流比例失调所导致的，以进行性呼吸窘迫及低氧血症为特征的综合征，为急性呼吸衰竭的一种类型，过去曾名休克肺、创伤性肺功能不全等，病死率很高。临床表现似新生儿呼吸窘迫综合征，但不属于未成熟肺。新生儿呼吸窘迫综合征是由于肺发育不成熟，原发性肺表面活性物质缺乏，只见于新生儿早期；本症多由于各种病因所致的继发性肺泡表面活性物质减损，可见于成人及新生儿早期后各年龄组小儿。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条